- Health and consumer strategic marketing group Cello reports strong trading for the year ended 31 December, with revenues and headline profits in line with consensus market expectations.

The group says Cello Health maintains strong headline revenue growth and 20% operating margins.

Other highlights:

- Recent investments in iS Healthcare Dynamics and Promedica already bedding in well

- Recent investments in overseas expansion performing to plan

- Good momentum into 2015 from strong bookings in Q4 2014

Preliminary results for year ended 31 December will be announced on 19 March.

At 8:05am: [LON:CLL] Cello Group PLC share price was -1p at 94.5p

Story provided by